Carmeliet P, Jain RK. Molecular mechanisms and clinical applications of angiogenesis. Nature. 2011;473(7347):298–307.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gupta GP, Massagué J. Cancer metastasis: building a framework. Cell. 2006;127(4):679–95.
Article
CAS
PubMed
Google Scholar
Höckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001;93(4):266–76.
Article
PubMed
Google Scholar
Kaplan RN, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature. 2005;438(7069):820–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Erler JT, et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell. 2009;15(1):35–44.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ohanian M, et al. Is acute myeloid leukemia a liquid tumor? Int J Cancer. 2013;133(3):534–43.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bakst RL, et al. How I treat extramedullary acute myeloid leukemia. Blood. 2011;118(14):3785–93.
Article
CAS
PubMed
Google Scholar
Lee KH, et al. Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course. Bone Marrow Transplant. 2003;32(8):835–42.
Article
CAS
PubMed
Google Scholar
Simpson DR, et al. High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation. Bone Marrow Transplant. 1998;22(3):259–64.
Article
CAS
PubMed
Google Scholar
Solh M, et al. Extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation: better prognosis than systemic relapse. Biol Blood Marrow Transplant. 2012;18(1):106–12.
Article
PubMed
Google Scholar
Choi SJ, et al. Treatment of relapsed acute myeloid leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a high incidence of isolated extramedullary relapse. Leukemia. 2004;18(11):1789–97.
Article
CAS
PubMed
Google Scholar
Yoshihara S, et al. Incidence of extramedullary relapse after haploidentical SCT for advanced AML/myelodysplastic syndrome. Bone Marrow Transplant. 2012;47(5):669–76.
Article
CAS
PubMed
Google Scholar
Stölzel F, et al. The prevalence of extramedullary acute myeloid leukemia detected by 18FDG-PET/CT: final results from the Prospective PETAML Trial. Haematologica. 2019. https://doi.org/10.3324/haematol.2019.223032.
Byrd JC, et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t (8;21)(q22;q22): results from Cancer and leukemia group B 8461. J Clin Oncol. 1997;15(2):466–75.
Article
CAS
PubMed
Google Scholar
Chang H, et al. Molecular cytogenetic abnormalities in patients with concurrent chronic lymphocytic leukemia and multiple myeloma shown by interphase fluorescence in situ hybridization: evidence of distinct clonal origin. Cancer Genet Cytogenet. 2004;148(1):44–8.
Article
CAS
PubMed
Google Scholar
Tallman MS, et al. Acute monocytic leukemia (French-American-British classification M5) does not have a worse prognosis than other subtypes of acute myeloid leukemia: a report from the eastern cooperative oncology group. J Clin Oncol. 2004;22(7):1276–86.
Article
PubMed
Google Scholar
Deeb G, et al. Genomic profiling of myeloid sarcoma by array comparative genomic hybridization. Genes Chromosom Cancer. 2005;44(4):373–83.
Article
CAS
PubMed
Google Scholar
Pileri SA, et al. Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. Leukemia. 2007;21(2):340–50.
Article
CAS
PubMed
Google Scholar
Tsimberidou AM, et al. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy. Leukemia. 2003;17(6):1100–3.
Article
PubMed
Google Scholar
Döhner K, et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood. 2005;106(12):3740–6.
Article
PubMed
CAS
Google Scholar
Falini B, et al. Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas. Leukemia. 2007;21(7):1566–70.
Article
CAS
PubMed
Google Scholar
Garzon R, et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A. 2008;105(10):3945–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ovcharenko D, et al. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia. Exp Hematol. 2011;39(10):1030–42 e7.
Article
CAS
PubMed
Google Scholar
Papadantonakis N, et al. Megakaryocyte pathology and bone marrow fibrosis: the lysyl oxidase connection. Blood. 2012;120(9):1774–81.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tadmor T, et al. The expression of lysyl-oxidase gene family members in myeloproliferative neoplasms. Am J Hematol. 2013;88(5):355–8.
Article
CAS
PubMed
Google Scholar
Dawes CS, et al. Enzyme-immobilized hydrogels to create hypoxia for in vitro cancer cell culture. J Biotechnol. 2017;248:25–34.
Article
CAS
PubMed
Google Scholar
Denko NC, et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene. 2003;22(37):5907–14.
Article
CAS
PubMed
Google Scholar
Pez F, et al. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Cancer Res. 2011;71(5):1647–57.
Article
CAS
PubMed
Google Scholar
Cox TR, et al. LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res. 2013;73(6):1721–32.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005;365(9460):671–9.
Article
CAS
PubMed
Google Scholar
Schaich M, et al. High-dose Cytarabine consolidation with or without additional Amsacrine and Mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial. J Clin Oncol. 2013;31(17):2094–102.
Article
CAS
PubMed
Google Scholar
Shaffer LG et al. An international system for human cytogenetic nomenclature (ISCN). 2009.
Google Scholar
Thiede C, et al. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood. 2006;107(10):4011–20.
Article
CAS
PubMed
Google Scholar
Thiede C, et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood. 2002;99(12):4326–35.
Article
CAS
PubMed
Google Scholar
Swerdlow SH, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues; 2008. p. 140–1.
Google Scholar
Palamakumbura AH, Trackman PC. A fluorometric assay for detection of lysyl oxidase enzyme activity in biological samples. Anal Biochem. 2002;300(2):245–51.
Article
CAS
PubMed
Google Scholar
Cheson BD, et al. Revised recommendations of the international working Group for Diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia. J Clin Oncol. 2003;21(24):4642–9.
Article
PubMed
Google Scholar
Contal C, O'Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal. 1999;30:253–70.
Article
Google Scholar
Bekassy AN, et al. Granulocytic sarcoma after allogeneic bone marrow transplantation: a retrospective European multicenter survey. Acute and chronic leukemia working parties of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 1996;17(5):801–8.
CAS
PubMed
Google Scholar
Yoshihara S, et al. Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse. Biol Blood Marrow Transplant. 2012;18(12):1800–7.
Article
PubMed
Google Scholar
Buck AK, et al. First demonstration of leukemia imaging with the proliferation marker 18F-fluorodeoxythymidine. J Nucl Med. 2008;49(11):1756–62.
Article
PubMed
Google Scholar
Stölzel F, et al. 18F-FDG-PET/CT for detection of extramedullary acute myeloid leukemia. Haematologica. 2011;96(10):1552–6.
Article
PubMed
PubMed Central
CAS
Google Scholar
Kwon M, et al. Evaluation of minimal residual disease by real-time quantitative PCR of Wilms' tumor 1 expression in patients with acute myelogenous leukemia after allogeneic stem cell transplantation: correlation with flow cytometry and chimerism. Biol Blood Marrow Transplant. 2012;18(8):1235–42.
Article
CAS
PubMed
Google Scholar
Tamaki H, et al. Molecular detection of AML1-MTG8-positive cells in peripheral blood from a patient with isolated extramedullary relapse of t (8;21) acute myeloid leukemia. Leukemia. 2009;23(2):424–6.
Article
CAS
PubMed
Google Scholar
Tsimberidou AM, et al. Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia. Cancer. 2008;113(6):1370–8.
Article
PubMed
PubMed Central
Google Scholar
Schaich M, et al. Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German acute myeloid leukemia intergroup. Haematologica. 2007;92(6):763–70.
Article
PubMed
Google Scholar
Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3(6):453–8.
Article
CAS
PubMed
Google Scholar
Cifone MA, Fidler IJ. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci U S A. 1981;78(11):6949–52.
Article
CAS
PubMed
PubMed Central
Google Scholar
De Toni F, et al. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene. 2006;25(22):3113–22.
Article
PubMed
CAS
Google Scholar
Stefanidakis M, et al. Role of leukemia cell invadosome in extramedullary infiltration. Blood. 2009;114(14):3008–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Baker AM, et al. Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis. Cancer Res. 2013;73(2):583–94.
Article
CAS
PubMed
Google Scholar